← Back to Screener
Japer Therapeutics, Inc. Warrants (JSPRW)
Price$0.01
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-95.07%
Price vs S&P 500 (4W)-21.14%
VGM Score4.06
All Metrics
Price vs S&P 500 (YTD)-76.63%
10-Day Avg Trading Volume0.02M
3-Month Avg Trading Volume0.02M
52-Week High$0.18
26-Week Price Return-81.19%
13-Week Price Return-71.11%
3-Month Return Std Dev238.34%
Year-to-Date Return-67.58%
5-Day Price Return-13.33%
Month-to-Date Return-29.73%
Price vs S&P 500 (13W)-79.98%
Beta2.86x
52-Week Low$0.01
mGradeF
vgmGradeF
Show chart for
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
JSPRWJaper Therapeutics, Inc. Warrants | — | — | F | $0.01 |
| AMGNAmgen Inc | C | C | C | $329.13 |
| GILDGilead Sciences Inc | C | B | C | $131.10 |
| ARGXargenx SE American Depositary Shares | D | A | C | $836.09 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $163.68 |
| BIIBBiogen Inc. Common Stock | B | D | B | $192.23 |
| BNTXBioNTech SE American Depositary Share | C | C | C | $91.70 |
| MRNAModerna, Inc. Common Stock | C | B | B | $46.06 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $161.00 |
| EXELExelixis Inc | C | B | B | $50.28 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | B | $298.10 |
About
Jasper Therapeutics is a clinical-stage biotech company developing safer conditioning agents and advanced stem cell engineering technologies to expand the use of hematopoietic stem cell transplantation and ex vivo gene therapy. The company's platform aims to enable broader patient access to stem cell-based treatments by improving efficacy and safety outcomes.